Confirmed Control (100%) Closed Transaction verified SupplementsConsumer Health

GSK Consumer Healthcare India (Horlicks) acquired by Hindustan Unilever and Unilever

Hindustan Unilever and Unilever acquired GSK Consumer Healthcare India (Horlicks), an India, Bangladesh & Asian Markets supplements brand, on Apr 1, 2020.

Transaction summary

Target
GSK Consumer Healthcare India (Horlicks)
Announced
2018-12-03
Completed
2020-04-01
Type
Acquisition
Deal type
Control
Stake acquired
100%
First added
2026-10-31
Latest update
2026-10-31

Value and multiples

100% enterprise value

EUR 5.3B

100% enterprise value | EUR

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

Approx. $6.0B USD using FX date 2018-12-03 at 1.1332 EUR/USD.

EV / revenue

9.63x

Period: FY2018

Basis: Public source

EV / EBITDA

-

EBITDA basis not stated

Basis: Public source

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: EUR 5.3B

Basis

  • Reported value: €5.29bn. Multiples use revenue of €550m (FY2018). Paid in cash and Hindustan Unilever shares; excludes the separate Bangladesh business.

Source summary

UNILEVER PLC - Form 20-F - FY2020

Confirmed

The total consideration paid was €5,294 million comprised of €449 million in cash and €4,845 million in shares of Hindustan Unilever Limited

Open source

Continue your research

Explore more comps →